Laboratory Corporation of America Holdings (LH)

Operating profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 736,800 1,225,500 1,347,200 1,509,700 1,856,600 2,221,300 2,614,200 2,889,500 3,259,500 3,822,100 4,102,300 3,695,900 2,445,400 1,488,600 781,400 819,400 1,330,200 1,301,500 1,305,000 1,338,500
Revenue (ttm) US$ in thousands 12,901,700 15,811,000 15,621,000 15,510,300 15,632,000 13,745,500 14,941,300 15,859,000 16,120,900 16,554,600 16,388,100 15,316,200 13,978,500 12,442,100 11,474,500 11,587,400 11,554,800 11,388,900 11,291,700 11,276,300
Operating profit margin 5.71% 7.75% 8.62% 9.73% 11.88% 16.16% 17.50% 18.22% 20.22% 23.09% 25.03% 24.13% 17.49% 11.96% 6.81% 7.07% 11.51% 11.43% 11.56% 11.87%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $736,800K ÷ $12,901,700K
= 5.71%

The operating profit margin of Laboratory Corp. Of America Holdings has shown a declining trend over the past several quarters, starting at 18.46% in Q1 2022 and decreasing to 9.24% in Q4 2023. This downward trend indicates that the company's profitability from its core operations has been decreasing over time.

The operating profit margin measures the proportion of revenue that remains as operating profit after accounting for operating expenses. The decreasing trend in the operating profit margin could suggest challenges in controlling costs or declining efficiency in generating profits from its core business activities.

It is important for stakeholders to closely monitor this trend and understand the underlying factors contributing to the decline in the operating profit margin to make informed decisions about the company's financial health and future prospects.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating profit margin
Laboratory Corporation of America Holdings
LH
5.71%
Fulgent Genetics Inc
FLGT
-67.61%
Quest Diagnostics Incorporated
DGX
13.87%
RadNet Inc
RDNT
6.11%